[ad_1] US President Trump has used targeted interventions to prevent drug companies from raising prices – at least for a while. It remains to be seen whether this will solve the structural …
Read More »
[ad_1] For other drugs, Merck wants to reduce customers by ten percent. Previously, the Swiss rival Novartis had obtained the applause of Trump by renouncing the price increases in the United States. …
Read More »
[ad_1] The US health care company is currently facing charges of killing more than 9,000 women with cancer in the United States, according to which baby powder sold by the United States. …
Read More »
[ad_1] Frankfurt High margins – low growth. This is the current state of the pharmaceutical industry, as evidenced by the latest sectoral analysis of the auditing and consulting group EY Experts examined …
Read More »
[ad_1] Comment In the stock market, the pharmaceutical company Novartis received many applause for the split of Alcon. But observers of Moody's solvency are worried for a good reason, Novartis delaying debt …
Read More »